Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. Oktober 2020 07:00 ET | Quelle: Mateon Therapeutics, Inc.

MATEON TO PARTICIPATE IN MERIDIAN CLINICAL TRIALS SUMMIT

AGOURA HILLS, California, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, today announced...
09. Mai 2019 07:00 ET | Quelle: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates

Continued progress made in four ongoing clinical studies as lenabasum advances towards 2020 data readouts in lead indications systemic sclerosis and cystic fibrosis Second clinical candidate...
12. März 2019 07:00 ET | Quelle: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates

●Pipeline of rationally-designed synthetic cannabinoids position Corbus to become the leader in treating inflammatory and fibrotic diseases by targeting the endocannabinoid system (ECS)...